Sheila Annie Peters
Papers
1
Total Citations
38
H-Index
1
About
Sheila Annie Peters is a distinguished researcher whose work bridges the frontiers of cancer biology and assay automation. Her key research areas include DNA damage response mechanisms, particularly the quantification of ionizing radiation-induced double-strand breaks, and the development of high-throughput immunocytochemistry platforms. Her most notable contribution is the pioneering "Development of an Automated γ-H2AX Immunocytochemistry Assay" (2009, 38 citations), which introduced a significantly automated method to quantify gamma-H2AX—a critical biomarker for DNA damage. This work, conducted using PC-3 and DU145 prostate cancer cells, has broad applications in assessing physiological responses to radiation exposure, offering a scalable tool for both basic radiobiology and clinical screening. By transforming a traditionally manual, labor-intensive process into an automated, reproducible assay, Peters has enabled more efficient evaluation of radiation effects and potential therapeutic interventions. Her achievement stands as a vital resource for researchers studying genomic instability and cancer treatment efficacy, demonstrating her impact in advancing translational methodologies that empower the scientific community.
Research Focus
Key Achievements
Top Papers
- 1Development of an Automated γ-H2AX Immunocytochemistry Assay38 citations · 2009